Table 2 Operative data and early postoperative outcome in patients with and without COVID-19 who had cardiac surgery from March 2020 through December 2021.
From: Testing for coronarvirus disease 2019 before cardiac surgery—safe outcome of infected patients
COVID-19 (n = 69) | Non COVID-19 (n = 1801) | P value | |
|---|---|---|---|
Urgent operation | 28(40.6) | 608(33.8) | |
Emergent operation | 3(4.3) | 106(5.9) | |
Valve surgery | 33(47.8) | 756(42.0) | 0.19 |
Isolate CABG | 27(39.1) | 591(32.8) | 0.34 |
Valve and CABG | 1(1.4) | 75(4.2) | 0.44 |
Aortic surgery | 5(7.2) | 286(15.9) | 0.76 |
Other procedures | 3(4.3) | 93(5.2) | 0.98 |
Mortality ≤ 30 days | 1 (0.9) | 20 (1.1) | 0.77 |
Re-entry for bleeding | 2 (2.9) | 84 (4.7) | 0.74 |
Stroke | 0 | 40 (2.2) | 0.42 |
Respirator ≥ 2 days | 2 (2.9) | 34 (1.9) | 0.84 |
Atrial fibrillation | 11 (15.9) | 374 (20.8) | 0.50 |
Pleuracentesis | 5 (7.2) | 70 (3.9) | 0.24 |
Pericardiocentesis | 3 (4.3) | 31 (1.7) | 0.23 |